Drug profile · INN
docusate + sennoside b
CO-SENNA
docusate + sennoside b (CO-SENNA) is an FDA-listed pharmaceutical active ingredient. Associated with Lacuna Pharma Pty Ltd.
TGA: approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — docusate + sennoside b
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.81
Quick answer
docusate + sennoside b (CO-SENNA) is an FDA-listed pharmaceutical active ingredient. Associated with Lacuna Pharma Pty Ltd.
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| TGA | approved | — |
Frequently asked questions
What is docusate + sennoside b?
docusate + sennoside b (CO-SENNA) is an FDA-listed pharmaceutical active ingredient. Associated with Lacuna Pharma Pty Ltd.
What is the brand name for docusate + sennoside b?
CO-SENNA is a marketed brand name for docusate + sennoside b. Check FDA Drugs@FDA for the current US label holder and prescribing information.